Alimera Sciences
Manufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6120 Windward Pkwy Ste 290, Alpharetta, ...Website
www.alimerasciences.ptRevenue
$8 MillionIndustry
About Alimera Sciences
Alimera Sciences Org Chart
Is Alimera Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Alimera Sciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Alimera Sciences
Check out if Alimera Sciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Alimera Sciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Alimera Sciences had a recent Job posting/layoffs
Earning: See what the market has to say on Alimera Sciences recently announced quarterly report
Alimera Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Alimera Sciences launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Alimera Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alimera Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alimera Sciences.
Alimera Sciences Tech Stack
A closer look at the technologies used by Alimera Sciences
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Alimera Sciences
Alimera Sciences is a global pharmaceutical company dedicated to developing innovative therapies that improve vision in chronic retinal diseases. The company focuses on conditions affecting the posterior segment of the eye, particularly the retina, aiming to address the inadequacies of current treatments that impact millions in an aging population.... Read More